T cells from healthy blood donors could recognize cancer antigens that were not recognized by the patients' own T cells, and gene transfer of the T-cell receptor back to the patients' T cells allowed them to also recognize the cancer antigens, suggesting that outsourcing antigen recognition might be one path to cancer immunotherapy.